MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$37,589,000
Net Income
$11,578,000
Net Profit Margin
30.80%
EPS
$0.35
Unit: Dollar
Revenue Breakdown
Product
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total net revenues
37,589,000
24,266,000
21,281,000
22,459,000
Product
12,176,000
-
-
-
License
0
0
0
0
Product Sales And Royalties
-
9,531,000
8,181,000
14,604,000
Product sales and royalties, net
12,176,000
9,531,000
8,181,000
14,604,000
Gross profit
25,413,000
14,735,000
13,100,000
7,855,000
Research and development
993,000
1,875,000
1,780,000
1,112,000
General and administrative
11,626,000
10,446,000
8,856,000
8,106,000
Total operating expenses
12,619,000
12,321,000
10,636,000
9,218,000
Income (gain) from operations
12,794,000
2,414,000
2,464,000
-1,363,000
Interest and other (expense) income, net
-
-
-1,050,000
-
Interest and other expense, net
-1,076,000
-840,000
-
-592,000
Income (gain) before income tax expense
11,718,000
1,574,000
1,414,000
-1,955,000
Income tax expense
140,000
20,000
-69,000
-28,000
Net income (gain)
11,578,000
1,554,000
1,483,000
-1,927,000
Basic EPS
0.42
0.06
0.055
-0.07
Diluted EPS
0.35
0.05
-
-0.07
Basic Average Shares
27,642,000
27,285,000
26,960,000
26,893,000
Diluted Average Shares
32,787,000
31,547,000
-
26,893,000
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Product
$37,589,000
Total net revenues
$37,589,000
(98.59%↑ Y/Y)
Gross profit
$25,413,000
(113.12%↑ Y/Y)
Product sales and
royalties, net
$12,176,000
(73.84%↑ Y/Y)
Income (gain) from
operations
$12,794,000
(967.39%↑ Y/Y)
Total operating
expenses
$12,619,000
(-5.82%↓ Y/Y)
Product
$12,176,000
Income (gain) before
income tax expense
$11,718,000
(565.18%↑ Y/Y)
Interest and other
expense, net
-$1,076,000
(-3.07%↓ Y/Y)
General and
administrative
$11,626,000
(20.02%↑ Y/Y)
Research and development
$993,000
(-73.25%↓ Y/Y)
Net income (gain)
$11,578,000
(547.89%↑ Y/Y)
Income tax expense
$140,000
(112.12%↑ Y/Y)
Buy us a coffee
Eton Pharmaceuticals, Inc. (ETON)
Eton Pharmaceuticals, Inc. (ETON)